-
miRNA–mRNA Modules in Juvenile Hormone Biosynthesis
2026-08-21
The reference study identifies coordinated miRNA–mRNA modules that release juvenile hormone biosynthetic genes during vitellogenesis in the migratory locust. Its combination of transcriptomics, validation assays, and agomiR perturbation connects post-transcriptional regulation in the corpora allata with vitellogenin expression and ovarian development.
-
TBST (Tris-Buffered Saline and Tween 20) Guide
2026-08-20
TBST helps reduce nonspecific binding and background in antibody-based workflows by combining buffered saline with the non-ionic detergent Tween 20. It is suitable for Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry, but should be validated or avoided when targets, surfaces, or downstream steps are detergent-sensitive.
-
Reporter mRNA as a Map for Translational Delivery
2026-08-20
A mechanistic and strategic guide to using capped, modified EGFP mRNA as a benchmark for delivery, translation, immune compatibility, and translational decision-making.
-
DFO for Latent Fingerprint Detection
2026-08-19
DFO combines amino acid reactivity with fluorescence to improve latent fingerprint visualization on paper and other porous evidence. This practical guide translates the product’s chemistry into a controlled workflow, quality checks, and troubleshooting strategy while using a zebrafish toxicology study as a model for orthogonal experimental validation.
-
GRE and α-MSH Models of Melanogenesis
2026-08-19
The reference study identifies a glabridin–resveratrol–ellagic acid combination as a strong in vitro candidate for suppressing melanogenesis while also showing antioxidant and anti-inflammatory activity. Its integrated use of B16F10, RAW264.7, DPPH, nitric oxide, and CREB–MITF assays provides a useful framework for interpreting multi-pathway activity, while leaving questions about synergy, dosing, and clinical transferability unresolved.
-
ARCA Cy3 EGFP mRNA: Assay Design Guide
2026-08-18
ARCA Cy3 EGFP mRNA (5-moUTP) enables researchers to separate cellular uptake, intracellular trafficking, and translation in mammalian-cell delivery assays. This mechanistic guide shows how to use its Cy3 and EGFP signals to interpret delivery performance rather than simply measure transfection intensity.
-
Cy5-UTP RNA Labeling: Workflow & Troubleshooting
2026-08-18
Cy5-UTP enables direct, far-red visualization of RNA produced by T7 in vitro transcription, with practical advantages for FISH, multiplex assays, and array workflows. This guide connects probe synthesis and quality control with emerging mRNA nanoparticle studies while clearly separating validated product use from exploratory delivery applications.
-
Thymosin-β4, Notch/NF-κB, and Limb Ischemia
2026-08-17
The reference study identifies a mechanistic link between thymosin-β4 and therapeutic angiogenesis in critical limb ischemia, connecting Notch activation with NF-κB signaling in endothelial cells and ischemic muscle. Its combined cell, animal, pharmacological inhibition, and molecular readouts provide a useful framework for evaluating pathway-dependent vascular repair while also highlighting limits of overexpression and inhibitor-based evidence.
-
LDH Cytotoxicity Assay Kit: Practical Workflow
2026-08-17
The LDH Cytotoxicity Assay Kit (SKU K2228) provides a non-radioactive approach to cell cytotoxicity measurement by quantifying LDH released into culture medium after membrane damage. It is suitable for comparative cell damage quantification and cytotoxicity screening, but LDH release alone should not be used to assign a specific death mechanism such as apoptosis.
-
SR 11302: AP-1 Signaling in Tumor Immunity
2026-08-16
SR 11302 is an AP-1 transcription factor inhibitor for dissecting how oncogenic transcription intersects with macrophage biology. This article interprets the compound as a mechanistic probe for tumor–immune assays, with practical guidance grounded in colorectal cancer research.
-
Standardized Whole-Blood Stimulation and Immunometabolism
2026-08-15
Zhao and colleagues present a standardized whole-blood stimulation protocol for testing how metabolic interventions reshape human immune responses. By combining defined immune stimuli, pathway-directed inhibitors, matched controls, and cytokine measurements, the workflow supports more reproducible immunometabolism studies while preserving the complexity of whole blood.
-
Estrogen–ERα/KRT19 Signaling in Papillary Thyroid Cancer
2026-08-14
This study integrates public transcriptomic analysis, Oxford Nanopore sequencing, cell perturbation experiments, and xenograft validation to examine how estrogen promotes papillary thyroid carcinoma. Its central finding is that estrogen receptor α activation engages KRT19 to support tumor-cell proliferation, migration, and invasion, while also highlighting important limits in translating this axis to patients.
-
tFUS, Nespas/miR-383-3p, and SHP2 After Stroke
2026-08-14
The reference study identifies a mechanistic link between low-intensity transcranial focused ultrasound and suppression of NLRP3-driven neuroinflammation after ischemic stroke. Its rat and microglial-cell experiments place the Nespas/miR-383-3p/SHP2 axis between neuromodulation and inflammasome regulation, providing a framework for testing SHP2-dependent microglial responses.
-
Plerixafor (AMD3100): CXCR4 Workflow Guide
2026-08-13
Plerixafor (AMD3100) provides a reversible way to interrogate CXCL12/CXCR4 signaling in tumor trafficking, stem cell release, and inflammatory cell movement. This practical guide connects concentration-controlled assays with the reference study’s platelet-extravasation findings, emphasizing workflow design, controls, and troubleshooting.
-
Chlorambucil: In Vitro Assay Workflows
2026-08-13
Chlorambucil is a practical DNA crosslinking model for separating growth arrest from true cell killing in cancer research. This workflow combines solvent control, time-resolved viability measurements, and orthogonal apoptosis assessment for more interpretable CLL, glioma, endothelial, and developmental cell studies.